menu
    • menu

    Company profile for InspireMD

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    InspireMD is a commercial-stage medical device company with proprietary and innovative stent designs with integrated embolic prevention systems (EPS) delivering neurovascular protection and stroke prevention. Proprietary MicroNet mesh addresses the primary shortcomings and harmful consequences of conventional Carotid stenting and surgery. InspireMD seeks to utilize its proprietary MicroNet™ technology to make its products th...
    InspireMD is a commercial-stage medical device company with proprietary and innovative stent designs with integrated embolic prevention systems (EPS) delivering neurovascular protection and stroke prevention. Proprietary MicroNet mesh addresses the primary shortcomings and harmful consequences of conventional Carotid stenting and surgery. InspireMD seeks to utilize its proprietary MicroNet™ technology to make its products the industry standard for sustained embolic protection, neurovascular protection and stroke prevention.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    InspireMDBelgium Flag
    Country
    Country
    Belgium
    Address
    Address
    Boulevard General Wahis, Brussels
    Telephone
    Telephone
    1-888-776-6804
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.inspiremd.com/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/inspiremd/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/InspireMD

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    InspireMD To Announce First Quarter 2026 Financial Results
    InspireMD To Announce First Quarter 2026 Financial Results

    27 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/27/3282017/0/en/inspiremd-to-announce-first-quarter-2026-financial-results.html

    GLOBENEWSWIRE
    27 Apr 2026
    Share Share
    InspireMD Releases 2025 Full-Year Financial Results
    InspireMD Releases 2025 Full-Year Financial Results

    18 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/18/3258036/0/en/InspireMD-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    18 Mar 2026
    Share Share
    Inspiremd To Unveil 2025 Q4 And Full-Year Financial Result
    Inspiremd To Unveil 2025 Q4 And Full-Year Financial Result

    09 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/09/3251873/0/en/InspireMD-to-Announce-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    09 Mar 2026
    Share Share
    Inspiremd Issues Inducement Grants Per Nasdaq LR 5635(C)(4)
    Inspiremd Issues Inducement Grants Per Nasdaq LR 5635(C)(4)

    20 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/20/3221760/0/en/InspireMD-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    20 Jan 2026
    Share Share
    InspireMD Announces Pivotal C-GUARDIANS Publication in JACC
    InspireMD Announces Pivotal C-GUARDIANS Publication in JACC

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3216952/0/en/InspireMD-Announces-Publication-of-the-C-GUARDIANS-Pivotal-Trial-Manuscript-in-the-Journal-of-the-American-College-of-Cardiology-JACC.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share
    CREST-2 Study In NEJM Shows Carotid Artery Stenting Benefits
    CREST-2 Study In NEJM Shows Carotid Artery Stenting Benefits

    24 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/24/3193398/0/en/Landmark-CREST-2-Study-Published-in-the-New-England-Journal-of-Medicine-Highlights-the-Benefits-of-Carotid-Artery-Stenting.html

    GLOBENEWSWIRE
    24 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search